Coronavirus Pandemic Forces FDA to Sharply Curtail Drug Company Inspections
The steep decline in oversight has stalled a number of new drug applications. The agency says it is trying to protect its employees but critics say inspectors should be considered essential workers and do their jobs.
Source: NYT Health - Category: Consumer Health News Authors: Sheila Kaplan Tags: Drugs (Pharmaceuticals) Shortages Factories and Manufacturing Medicine and Health Food and Drug Administration Bristol Myers Squibb Company Mylan Inc Spectrum Pharmaceuticals Inc Nivagen Biocon Biologics your-feed-healthcare Source Type: news
More News: Coronavirus | COVID-19 | Food and Drug Administration (FDA) | Health | Jobs | New Drug Applications | Pandemics